BriaCell Therapeutics Corp. (BCTX) stock
BCTXNasdaqPharmaceutical PreparationsFiscal year ends July 31Also trades as BCTXL, BCTXZ
Số liệu tài chính tới Q4 năm tài chính 2026, quý kết thúc ngày Jul 31, 2026Last filing: 10-K on Oct 28, 2026Score 4/30
$3.06−0.10 (-3.16%)
Close on Nov 20, 2026Market cap $26.72MP/E –Yield –
BriaCell Therapeutics free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
BriaCell Therapeutics's free cash flow for the twelve months ending Jul 31, 2026 was -$28.78M. For fiscal 2026 it was -$28.78M.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jul 31, 2026 | -$28.78M | – |
| FY2024 | Jul 31, 2024 | -$24.58M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jul 31, 2026 | -$5.96M | – |
See a number that looks wrong?